Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo

被引：3
|
作者：
Daoussis, Dimitrios [1 ]
Andonopoulos, Andrew P. [1 ]
机构：
[1] Univ Patras, Sch Med, Patras Univ Hosp, Div Rheumatol,Dept Internal Med, Patras 26504, Greece
来源：
RHEUMATOLOGY INTERNATIONAL | 2011年 / 31卷 / 06期
关键词：
Systemic sclerosis; Scleroderma; Rituximab; Interstitial lung disease; B cells; Fibrosis; Skin thickening; Rheumatic diseases;
D O I：
10.1007/s00296-010-1485-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Several lines of evidence from basic research indicate that B cells may contribute to the pathogenesis of systemic sclerosis. Clinical studies as well have provided preliminary data pointing to the direction that B-cell depletion with rituximab might be a therapeutic option for patients with this debilitating disease.
引用
收藏
页码：841 / 842
页数：2
相关论文
共 50 条
  • [1] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    Rheumatology International, 2011, 31 : 841 - 842
  • [2] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [3] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [4] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [5] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [6] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [7] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
  • [8] Systemic sclerosis-associated interstitial lung disease
    Perelas, Apostolos
    Silver, Richard M.
    Arrossi, Andrea, V
    Highland, Kristin B.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 304 - 320
  • [9] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [10] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
12345